NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/11/2025
Back to search
Official data from USPTO
PURIST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/11/2025
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
12/22/2022
Registration date
03/11/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
03/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-04-00
First use in commerce
2024-04-00
Drawing code
4
Owner type
03
Owner location
Durham, NC
Examiner
JOINER, KATINA JACKSON
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GENECENTRIC THERAPEUTICS, INC.
Representatives
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical and scientific research in the field of oncologytumor biologydiagnosis and treatment of cancers; Pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosisprognosistherapypreventiontreatment and patient management; Providing research and development services in the field of oncology; Research and development in the field of RNA expressioncancer biology; Research and development services for othersresearch and development of assays for oncological testing and diagnostic purposes; Scientific research in the field of RNA expression analysis and reporting; Providing laboratory research services in the field of pancreatic cancer; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Pharmaceutical and medical research in the field of survival outcomes and standard of care research; Medical research featuring the identification and validation of cancer related biomarkers and RNA expression for use in improved patient outcomes; Providing a website and information in the field of medical research and scientific research in the fields of tumor biologyoncologydiagnosis and treatment of cancers
Class 44
Medical testing services for diagnosisprognosistreatmentmanagement of cancer; Medical testing for diagnostic and treatment option purposes; Providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosisprognosistreatment or management of cancer; Provision of health care servicesproviding oncological testing reports to physicians
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/20/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/13/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/13/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/13/2025
EX1G
SOU EXTENSION 1 GRANTED
02/13/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
02/13/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/10/2024
IUAF
USE AMENDMENT FILED
10/01/2024
EXT1
SOU EXTENSION 1 FILED
10/01/2024
DRRR
DIVISIONAL REQUEST RECEIVED
10/01/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/01/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/01/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/01/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/19/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/19/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/22/2023
GNRT
NON-FINAL ACTION E-MAILED
09/22/2023
CNRT
NON-FINAL ACTION WRITTEN
09/22/2023
DOCK
ASSIGNED TO EXAMINER
09/22/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2023
NWAP
NEW APPLICATION ENTERED
12/26/2022
Continuous trademark protection
Get notified about every new filing that threatens PURIST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.